Related Experiment Video
Updated: May 29, 2026
05:58
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Healing the diabetic heart: does myocardial preconditioning work?
Pitchai Balakumar1, Nidhi Krishan Sharma
1Cardiovascular Pharmacology Division, Department of Pharmacology, Rajendra Institute of Technology and Sciences (RITS), Sirsa, India. pbala2006@gmail.com
Cellular Signalling
|September 28, 2011
Summary
Ischemic preconditioning may not protect diabetic hearts from injury, despite its benefits in non-diabetic hearts. This review explores why diabetes mellitus might abolish these protective effects and discusses potential mechanisms.
Area of Science:
- Cardiovascular Science
- Metabolic Disease Research
- Cellular Cardioprotection
Background:
- Ischemic heart disease is a significant public health issue, particularly in industrialized nations.
- Myocardial ischemia-reperfusion (I/R) injury can worsen damage after restoring blood flow.
- Ischemic preconditioning offers protection against I/R injury, but its efficacy in diabetic hearts is debated.
Purpose of the Study:
- To review the conflicting evidence regarding diabetes mellitus's impact on I/R injury.
- To assess the protective potential of ischemic preconditioning in diabetic hearts.
- To elucidate the mechanisms behind the attenuated cardioprotective effects in diabetic hearts.
Main Methods:
- Literature review of studies on diabetes mellitus and myocardial I/R injury.
- Analysis of research investigating ischemic preconditioning in diabetic models.
- Discussion of molecular and cellular mechanisms involved.
Main Results:
- Diabetes mellitus can paradoxically suppress the cardioprotective effects of ischemic preconditioning.
- Deficits in survival pathways, mitochondrial dysfunction, and oxidative stress are implicated.
- Controversial results highlight the need for further research into these disparities.
Conclusions:
- Understanding the mechanisms of attenuated preconditioning is crucial for developing effective therapeutic strategies.
- Targeting specific pathways may restore cardioprotection in diabetic hearts.
- Further research is needed to optimize preconditioning protocols for diabetic patients.
More Related Videos
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...